Related Experiment Video
Updated: Aug 2, 2026

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
Published on: March 20, 2012
In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing müllerian system
K Block1, A Kardana, P Igarashi
1Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Abstract:
Diethylstilbestrol (DES) was widely used to treat pregnant women through 1971. The reproductive tracts of their female offspring exposed to DES in utero are characterized by anatomic abnormalities. Here we show that DES administered to mice in utero produces changes in the expression pattern of several Hox genes that are involved in patterning of the reproductive tract. DES produces posterior shifts in Hox gene expression and homeotic anterior transformations of the reproductive tract. In human uterine or cervical cell cultures, DES induces HOXA9 or HOXA10 gene expression, respectively, to levels approximately twofold that induced by estradiol. The DES-induced expression is not inhibited by cyclohexamide. Estrogens are novel morphogens that directly regulate the expression pattern of posterior Hox genes in a manner analogous to retinoic acid regulation of anterior Hox genes. Alterations in HOX gene expression are a molecular mechanism by which DES affects reproductive tract development. Changes in Hox gene expression are a potential marker for the effects of in utero drug use that may become apparent only at late stages of development.
Insights
Diethylstilbestrol (DES) exposure in utero alters Hox gene expression, causing reproductive tract abnormalities in offspring. These changes in HOX gene patterns may serve as a marker for developmental effects of in utero drug exposure.
Area of Science:
- Developmental biology
- Endocrinology
- Genetics
Background:
- Diethylstilbestrol (DES) was prescribed to pregnant women until 1971, leading to reproductive abnormalities in female offspring.
- Hox genes are crucial for the development and patterning of the reproductive tract.
Purpose of the Study:
- To investigate the molecular mechanisms by which in utero DES exposure affects reproductive tract development.
- To determine if DES alters Hox gene expression patterns in exposed offspring.
Main Methods:
- DES was administered to pregnant mice to assess effects on offspring reproductive tract development and Hox gene expression.
- Human uterine and cervical cell cultures were used to study DES effects on HOXA9 and HOXA10 gene expression.
Main Results:
- In utero DES exposure in mice resulted in posterior shifts of Hox gene expression and anterior homeotic transformations of the reproductive tract.
- DES significantly increased HOXA9 and HOXA10 gene expression in human cell cultures, an effect not blocked by cyclohexamide.
- Estrogen acts as a morphogen, directly regulating posterior Hox gene expression.
Conclusions:
- Altered HOX gene expression is a key molecular mechanism underlying DES-induced reproductive tract malformations.
- Changes in Hox gene expression may serve as a biomarker for developmental effects of in utero drug exposure, potentially manifesting later in life.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Teratogenicity
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...

